Kiniksa Pharmaceuticals
KNSA
KNSA
108 hedge funds and large institutions have $526M invested in Kiniksa Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 39 increasing their positions, 29 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
4% more funds holding
Funds holding: 104 → 108 (+4)
2.68% more ownership
Funds ownership: 91.42% → 94.09% (+2.7%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
108
Holding in Top 10
–
Calls
$3.06M
Puts
$2.19M
Top Buyers
| 1 | +$36.2M | |
| 2 | +$20.6M | |
| 3 | +$17.1M | |
| 4 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
+$10.6M |
| 5 |
Goldman Sachs
New York
|
+$7.86M |
Top Sellers
| 1 | -$36.4M | |
| 2 | -$17.6M | |
| 3 | -$6.93M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$4.33M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
-$4.27M |